Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: The Study to Reduce Intravenous Exposures (STRIVE)

Journal of Urban Health

Volumn 84, Issue 1, 2007, Pages 99-115

  Kapadia, Farzana ^a   Latka, Mary H ^b,i   Hagan, Holly ^c   Golub, Elizabeth T ^d   Campbell, Jennifer V ^e   Coady, Micaela H ^f   Garfein, Richard S ^g   Thomas, David L ^h   Bonner, Sebastian ^f   Thiel, Thelma ⁱ   Strathdee, Steffanie A ^d,g  

^a GUTTMACHER INSTITUTE   (United States)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^f NEW YORK ACADEMY OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ Hepatitis Foundation International   (United States)

Author keywords

Behavioral intervention; Health care utilization; Hepatitis C virus; Injection drug user; Randomized trial

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; BEHAVIORAL RESEARCH; CONTROLLED STUDY; DRUG ABUSE; DRUG ABUSE PATTERN; DRUG USE; EMERGENCY WARD; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LIVER FUNCTION TEST; MALE; MEDICAL CARE; METHODOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED STATES; VEIN PUNCTURE; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; BEHAVIOR THERAPY; EQUIPMENT REUSE; FEASIBILITY STUDIES; FEMALE; HEALTH BEHAVIOR; HEALTH SERVICES; HEALTH SERVICES ACCESSIBILITY; HEPATITIS C; HUMANS; MALE; NEEDLE SHARING; PREVENTIVE HEALTH SERVICES; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 33846413986     PISSN: 10993460     EISSN: 14682869     Source Type: Journal    
DOI: 10.1007/s11524-006-9133-7     Document Type: Article

References (38)

1. NIH consensus statement on management of hepatitis C: 2002. NIH Consens State Sci Statements. 2002;19:1-46.
2. Williams I. Epidemiology of hepatitis C in the United States. Am J Med. 1999;107:2S-9S.
3. Yen T, Keeffe EB, Ahmed A. The epidemiology of hepatitis C virus infection. J Clin Gastroenterol. 2003;36:47-53.
4. Alter MJ, Mast EE, Moyer LA, Margolis HS. Hepatitis C. Infect Dis Clin North Am. 1998;12:13-26.
5. Thorpe LE, Ouellet LJ, Hershow R, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002;155:645-653.
6. Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Human Retrovirol. 1998;18(Suppl 1):S11-S19.
7. Thorpe L, Ouellet L, Hershow R, Bailey S, Williams I, Monerosso E. The multiperson use of non-syringe injection equipment and risk of hepatitis c infection in a cohort of young adult injection drug users in Chicago, 1997-1999. Ann Epidemiol. 2000;10:472-473.
8. Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health. 2001;91:42-46.
9. Gerberding JL. Management of occupational exposures to blood-borne viruses. N Engl J Med. 1995;332:444-451.
10. Hagan H, Des Jarlais DC. HIV and HCV infection among injecting drug users. Mt Sinai J Med. 2000;67:423-428.
11. Stoove MA, Gifford SM, Dore GJ. The impact of injecting drug use status on hepatitis C-related referral and treatment. Drug Alcohol Depend. 2005;77:81-86.
12. Stephenson J. Former addicts face barriers to treatment for HCV. JAMA. 2001;285:1003-1005.
13. Strauss SM, Astone JM, Jarlais DD, Hagan H. A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States. Drug Alcohol Depend. 2004;73:227-236.
14. Ompad DC, Fuller CM, Vlahov D, Thomas D, Strathdee SA. Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. Clin Infect Dis. 2002;35:783-788.
15. Hagan H, McGough JP, Thiede H, Weiss NS, Hopkins S, Alexander ER. Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol. 1999;149:203-213.
16. Crofts N, Nigro L, Oman K, Stevenson E, Sherman J. Methadone maintenance and hepatitis C virus infection among injecting drug users. Addiction. 1997;92:999-1005.
17. Strauss SM, Astone JM, Hagan H, Des J. The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units. J Urban Health. 2004;81:38-47.
18. Garfein RS, Latka M, Hagan H, et al. CIDUS-III/Drug Users Intervention Trial (DUIT): A Randomized, Controlled Trial of a Peer-Education Behavioral Intervention to Prevent HIV and Hepatitis C Virus Infection Among 15-30 Year Old Injection Drug Users. Paper Presented at: National HIV Prevention Conference; June 12, 2005; Atlanta, GA.
19. Alter MJ, Kuhnert WL, Finelli L. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR Morb Mortal Wkly Rep. 2003;52:1-13.
20. Fishbein M, Ajzen F. Belief, Attitude and Behavior: An Introduction to Theory and Research. Reading, MA: Addison-Wesley; 1975.
21. Montano DE, Kasprzyk D, Taplin SH. The Theory of Reasoned Action and the Theory of Planned Behavior. In: Glanz K, Lewis FM, Rimer BK, eds. Health Behavior and Health Education. San Francisco, CA: Jossey-Bass Publishers; 1997.
22. Bandura A. Self-efficacy mechanism in human agency. Am Psychol. 1986;40:359-373.
23. Bandura A. A Social-Cognitive Approach to the Exercise of Control over AIDS Infection. In: Albee GW, Schneider SF, eds. Primary Prevention of AIDS: Psychological Approaches. Newbury Park, CA: Sage Publications; 1991.
24. Rothman KJ, Greenland S. Modern Epidemiology, 2nd edition. Philadelphia, PA: Lippincott-Raven; 1998.
25. Hagan H, Campbell JV, Thiede H, et al. Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Rep. 2006;121:710-719.
26. Rosenblum A, Nuttbrock L, McQuistion HL, Magura S, Joseph H. Hepatitis C and substance use in a sample of homeless people in New York City. J Addict Dis. 2001;20:15-25.
27. Klinkenberg WD, Caslyn RJ, Morse GA, et al. Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders. Compr Psychiatry. 2003;44:293-302.
28. Stein JA, Nyamathi A. Correlates of hepatitis C virus infection in homeless men: a latent variable approach. Drug Alcohol Depend. 2004;75:89-95.
29. Macalino GE, Vlahov D, Sanford-Colby S, et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health. 2004;94:1218-1223.
30. Reindollar RW. Hepatitis C and the correctional population. Am J Med. 1999;107:100S-103S.
31. Samuel MC, Doherty PM, Bulterys M, Jenison SA. Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA. Epidemiol Infect. 2001;127:475-484.
32. Gebo KA, Diener-West M, Moore RD. Hospitalization rates differ by hepatitis C status in an urban HIV cohort. J Acquir Immune Defic Syndr. 2003;34:165-173.
33. Wiegand J, Buggisch P, Boecher W, et al. Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study. Hepatology. 2006;43:250-256.
34. Jaeckel E, Cornberg M, Wedemeyer H, et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med. 2001;345:1452-1457.
35. Hagan H, Latka MH, Campbell JV, et al. Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities. Clin Infect Dis. 2006;42:669-672.
36. Turner CF, Ku L, Rogers SM, Lindberg LD, Pleck JH, Sonenstein FL. Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology. Science. 1998;280:867-873.
37. Des Jarlais DC, Paone D, Milliken J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet. 1999;353:1657-1661.
38. Metzger DS, Koblin B, Turner C, et al. Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. Am J Epidemiol. 2000;152:99-106.